BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25956271)

  • 21. Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.
    Bowles EJA; Yu O; Ziebell R; Chen L; Boudreau DM; Ritzwoller DP; Hubbard RA; Boggs JM; Burnett-Hartman AN; Sterrett A; Fujii M; Chubak J
    BMC Cancer; 2019 Mar; 19(1):270. PubMed ID: 30917783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
    Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
    [No Abstract]   [Full Text] [Related]  

  • 23. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
    Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
    Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer recurrence in relation to antidepressant use.
    Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
    Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
    Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
    Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
    Kowall B; Rathmann W; Kostev K
    Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
    Baglia ML; Cui Y; Zheng T; Yang G; Li H; You M; Xu L; Murff H; Gao YT; Zheng W; Xiang YB; Shu XO
    Cancer Res Treat; 2019 Apr; 51(2):538-546. PubMed ID: 29986576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study.
    Yang J; Vallarino C; Bron M; Perez A; Liang H; Joseph G; Yu S
    Curr Med Res Opin; 2014 Nov; 30(11):2223-31. PubMed ID: 24983744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.
    Obi N; Heinz J; Seibold P; Vrieling A; Rudolph A; Chang-Claude J; Berger J; Flesch-Janys D
    Int J Cancer; 2016 May; 138(9):2098-108. PubMed ID: 26649645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy for diabetes is associated with increased use of lower endoscopy.
    Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP; Habel LA
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1195-202. PubMed ID: 17603822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
    Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
    Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
    Ameijide A; Clèries R; Carulla M; Buxó M; Marcos-Gragera R; Martínez JM; Vilardell ML; Vilardell M; Espinàs JA; Borràs JM; Izquierdo Á; Galceran J
    Clin Transl Oncol; 2019 Aug; 21(8):1014-1025. PubMed ID: 30607790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
    He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
    Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.
    Gong Z; Aragaki AK; Chlebowski RT; Manson JE; Rohan TE; Chen C; Vitolins MZ; Tinker LF; LeBlanc ES; Kuller LH; Hou L; LaMonte MJ; Luo J; Wactawski-Wende J
    Int J Cancer; 2016 Apr; 138(8):1915-27. PubMed ID: 26616262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
    Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW
    Breast Cancer Res Treat; 2011 Sep; 129(2):549-56. PubMed ID: 21479924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.